PharmaCyte Biotech Inc (PMCB) — Tangible Net Worth Ratio
PharmaCyte Biotech Inc (PMCB) has a Tangible Net Worth Ratio of 100.0% as of April 2026. This metric is calculated by deducting intangible assets ($0.00) from net assets ($34.98 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore PMCB net assets growth trend to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
PharmaCyte Biotech Inc Tangible Net Worth Ratio (2006–2026)
This chart shows how PharmaCyte Biotech Inc's Tangible Net Worth Ratio has changed across 17 annual periods from 2006 to 2026. As of April 2026, the ratio stands at 100.0%, reflecting net assets of $34.98 Million with intangible assets of $0.00 USD. For live market cap and overall valuation, see PharmaCyte Biotech Inc market cap and net worth.
Annual Tangible Net Worth Ratio for PharmaCyte Biotech Inc (2006–2026)
The table below presents the year-by-year Tangible Net Worth Ratio for PharmaCyte Biotech Inc from 2006 to 2026, covering 17 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See PMCB FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2026 | 100.0% | $34.98 Million | $0.00 | $46.75 Million | ▲ +3.0 pp |
| 2025 | 97.0% | $51.89 Million | $1.55 Million | $55.17 Million | ▲ +0.9 pp |
| 2024 | 96.1% | $39.51 Million | $1.55 Million | $59.90 Million | ▲ +1.0 pp |
| 2023 | 95.1% | $72.69 Million | $3.55 Million | $73.28 Million | ▼ -0.9 pp |
| 2022 | 96.1% | $89.92 Million | $3.55 Million | $90.62 Million | ▲ +49.2 pp |
| 2021 | 46.9% | $6.68 Million | $3.55 Million | $7.40 Million | ▲ +16.6 pp |
| 2020 | 30.3% | $5.09 Million | $3.55 Million | $6.17 Million | ▲ +0.7 pp |
| 2019 | 29.6% | $5.04 Million | $3.55 Million | $5.78 Million | ▼ -8.9 pp |
| 2018 | 38.5% | $5.77 Million | $3.55 Million | $6.41 Million | ▼ -17.6 pp |
| 2017 | 56.1% | $8.09 Million | $3.55 Million | $8.67 Million | ▲ +10.5 pp |
| 2016 | 45.6% | $6.52 Million | $3.55 Million | $7.16 Million | ▲ +5.4 pp |
| 2015 | 40.2% | $5.94 Million | $3.55 Million | $7.95 Million | ▼ -20.1 pp |
| 2014 | 60.3% | $8.94 Million | $3.55 Million | $9.32 Million | ▼ -34.1 pp |
| 2009 | 94.4% | $3.12 Million | $174.04K | $6.04 Million | ▲ +6.0 pp |
| 2008 | 88.4% | $7.44 Million | $863.40K | $7.62 Million | ▲ +8.5 pp |
| 2007 | 79.8% | $4.29 Million | $863.87K | $4.41 Million | ▼ -20.2 pp |
| 2006 | 100.0% | $4.41 Million | $0.00 | $5.14 Million | — |